Who Generates Higher Gross Profit? Amgen Inc. or Perrigo Company plc

Amgen Inc. vs. Perrigo Company plc: A Decade of Gross Profit Comparison

In the competitive landscape of the pharmaceutical industry, understanding which companies lead in profitability is crucial. Over the past decade, Amgen Inc. has consistently outperformed Perrigo Company plc in terms of gross profit. From 2014 to 2023, Amgen's gross profit has shown a steady upward trend, peaking in 2022 with a remarkable 27% increase from its 2014 figures. In contrast, Perrigo's gross profit, while showing some growth, has remained significantly lower, with its highest point in 2016, reaching only about 10% of Amgen's peak in 2022.

This data highlights Amgen's robust financial health and strategic market positioning, making it a dominant player in the industry. Investors and stakeholders can glean valuable insights from these trends, emphasizing the importance of strategic growth and innovation in maintaining competitive advantage.